Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL
1995 · Nature · 953 citations
https://doi.org/10.1038/373432a0
E
Erica L. Mayer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
354
Papers
9.7K
Citations
44
h-index
92
i10-index
Erica L. Mayer is an academic researcher from Dana-Farber Cancer Institute. The author has contributed to research in topics: Advanced Breast Cancer Therapies & Cancer Treatment and Pharmacology & Breast Cancer Treatment Studies. The author has an h-index of 44, co-authored 301 publications.
ORCID: 0000-0001-5430-8957Papers by this author
worksPalbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
2021 · The Lancet Oncology · 250 citations
https://doi.org/10.1016/s1470-2045(20)30642-2
Genomic profiling of ER <sup>+</sup> breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance
2017 · Science Translational Medicine · 122 citations
https://doi.org/10.1126/scitranslmed.aai7993
A Phase 2 Trial of Dasatinib in Patients with Advanced HER2-Positive and/or Hormone Receptor–Positive Breast Cancer
2011 · Clinical Cancer Research · 104 citations
https://doi.org/10.1158/1078-0432.ccr-11-0070
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer
2024 · Journal of Clinical Oncology · 98 citations
https://doi.org/10.1200/jco.23.01940
Single duplex DNA sequencing with CODEC detects mutations with high sensitivity
2023 · Nature Genetics · 72 citations
https://doi.org/10.1038/s41588-023-01376-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat